sn 38 has been researched along with 10,11-methylenedioxy-20-camptothecin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fan, Y; Kohn, KW; Pommier, Y; Shi, LM; Weinstein, JN | 1 |
Bearss, D; Manikumar, G; Von Hoff, DD; Wadkins, RM; Wall, ME; Wani, MC | 1 |
2 other study(ies) available for sn 38 and 10,11-methylenedioxy-20-camptothecin
Article | Year |
---|---|
Molecular modeling studies of the DNA-topoisomerase I ternary cleavable complex with camptothecin.
Topics: Amino Acid Substitution; Antineoplastic Agents; Binding Sites; Camptothecin; DNA; DNA Topoisomerases, Type I; Drug Resistance, Neoplasm; Enzyme Inhibitors; Hydrogen Bonding; Ligands; Models, Molecular; Molecular Conformation; Mutation; Protein Conformation; Stereoisomerism; Structure-Activity Relationship; Thermodynamics; Topoisomerase I Inhibitors | 1998 |
Camptothecin analogs with bulky, hydrophobic substituents at the 7-position via a Grignard reaction.
Topics: Antineoplastic Agents; Camptothecin; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; Ketones; Structure-Activity Relationship; Topoisomerase I Inhibitors | 2004 |